Publications by authors named "Janice Seinfeld"
Article Synopsis
- Infant vaccination rates in Peru have dropped recently, worsened by the COVID-19 pandemic, leading to a proposal to switch to a new hexavalent vaccine in the national immunization program to improve coverage.
- A cost-effectiveness analysis examined different vaccination scenarios over a 5-year period for nearly half a million children born in 2020, assessing various outcomes including coverage rates and healthcare costs.
- The analysis found that moving to the hexavalent vaccine could increase coverage significantly, with costs rising based on different delivery scenarios, highlighting the importance of effective vaccination strategies for public health.
Objectives: Type 2 diabetes mellitus (T2DM) represents an increasing public health problem in Peru. This study aims to estimate the national economic burden of this disease for the public funder, the social security, and private sector insurers.
Methods: Direct healthcare costs were estimated for a cohort of 45-to-75-year-old adults diagnosed with T2DM in 2019, over a 20-year period.
Background: This study aimed to estimate the economic impact of replacing the current Peruvian primary immunization scheme for infants under 1 year old with an alternative scheme with similar efficacy, based on a hexavalent vaccine.
Methods: A cost-minimization analysis compared the costs associated with vaccine administration, adverse reactions medical treatment, logistical activities, and indirect social costs associated with time spent by parents in both schemes. A budgetary impact analysis assessed the financial impact of the alternative scheme on healthcare budget.
Objectives: In Peru, a country with constrained health resources, breast cancer control is characterized by late stage treatment and poor survival. To support breast cancer control in Peru, this study aims to determine the cost-effectiveness of different breast cancer control interventions relevant for the Peruvian context.
Methods: We performed a cost-effectiveness analysis (CEA) according to WHO-CHOICE guidelines, from a healthcare perspective.
As health care costs increase, cost-control mechanisms become more widespread and it is crucial to understand their implications for the health care market. This paper examines the effect that managed care activity (based on the aim to control health care expenditure) has on the adoption of technologies by hospitals. We use a hazard rate model to investigate whether higher levels of managed care market share are associated with a decrease on medical technology adoption during the period 1982-1995.
View Article and Find Full Text PDF